Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
What is the purpose of this trial?
The purpose of this trial is to test a deescalated 3-fraction stereotactic body radiotherapy (SBRT) regimen to 45 Gray (Gy) in 3 fractions for centrally located thoracic tumors.
- Trial withYale Cancer Center
- Start Date03/01/2020
- End Date07/30/2021
- Last Updated05/29/2020
- Study HIC#2000025868